Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

27.37 +0.29 (+1.07%)
Official Closing Price Updated: 7:00 PM EDT, Oct 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
99 100 Next >
What's going on in today's session: S&P500 most active stocks
Let's have a look at what is happening on the US markets on Monday. Below you can find the most active S&P500 stocks in today's session. 
Via Chartmill
This Strategy Always Outperforms In Bear Markets
 
Via Benzinga
Trump’s Trade Twist Sends Stocks Soaring
Stocks are firmly higher Monday, as a surprise tariff exemption from President Donald Trump sparked a rally in the tech sector. 
Via Talk Markets
Topics Government Stocks / Equities World Trade
Novo Nordisk Warns Against Counterfeit Ozempic In US: Retail’s Unmoved
The company said the seized counterfeit products feature lot number PAR0362 and illegitimate serial numbers beginning with the first eight digits, 51746517. 
Via Stocktwits
Topics Economy
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today
Pfizer bows, but is not entirely out of the GLP-1 race. 
Via The Motley Fool
What's Going On With Viking Therapeutics, Structure Therapeutics Stock On Monday?
Pfizer ends danuglipron development after liver safety issue, boosting shares of Viking, Eli Lilly, and Novo Nordisk amid obesity drug competition. 
Via Benzinga
Meta’s Antitrust Trial Over Instagram, WhatsApp Acquisition To Begin Today: Chief Legal Officer Says FTC’s Case ‘Ignores Reality’
The social media giant acquired Instagram in 2012 for $1 billion and WhatsApp in a highly competitive bid in 2014 for a whopping $19 billion, beating Google to the punch. 
Via Stocktwits
Topics Government Lawsuit
Breaking New Study: mRNA Vaccines Trigger 620% Heart Risk Surge in Young Men
A groundbreaking study published in the International Journal of Cardiovascular Research & Innovation reveals alarming long-term heart risks linked to COVID-19 mRNA vaccines, challenging official... 
Via Newsworthy
Pfizer Discontinues Once-Daily Weight Loss Pill Over Liver Injury In One Patient
Pfizer has ended development of danuglipron, an oral GLP-1 drug for weight management, citing clinical data and regulatory input. 
Via Benzinga
Starbucks Updates Dress Code For Baristas To Offer Consistent Experience
Baristas must wear a solid black top and a denim bottom in any shade of khaki, blue, or black. 
Via Stocktwits
Topics Workforce
Third Harmonic Bio Announces Liquidation Plan: Stock Skyrockets 39% Pre-Market, But Retail’s Shattered
The company plans to file a certification of dissolution with the Secretary of the State of Delaware in the third quarter of 2025, provided that stockholders authorize the decision at its annual... 
Via Stocktwits
Pfizer Ends Development Of Weight Loss Pill Due To Potential Drug-Induced Liver Injury In A Patient
According to Pfizer, the reported patient’s liver enzymes “recovered rapidly” after they stopped taking the company’s experimental weight loss pill. 
Via Stocktwits
Topics Government
Pfizer Scraps Obesity Pill After Potential Drug-Tied Liver Injury
The company is continuing to test a daily pill that blocks GIPR. 
Via Investor's Business Daily
Pfizer Provides Update on Oral GLP-1 Receptor Agonist Danuglipron
From Pfizer Inc.
Via Business Wire
SaveRxCanada.to Offers Affordable Access to Palbociclib (Ibrance) from India
April 14, 2025 -- Breast Cancer Patients Can Save Thousands Monthly with Trusted Generic "Palnat" at Just $4.38 Per Capsule 
Via 24-7 Press Release
Topics Supply Chain
Benzinga Bulls And Bears: Apple, Nike, US Steel — And The Markets Ride Out Ongoing Volatility
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories. 
Via Benzinga
1 Deeply Undervalued Stock to Buy in the Market Correction
Via The Motley Fool
Topics Government World Trade
Which S&P500 stocks are the most active on Friday?
Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Friday. Discover the stocks that are generating the highest... 
Via Chartmill
Building Wealth Through Economics: A Patriotic Investor’s Guide To Tariffs 2.0 And Why
Massive container ports and supply chains worldwide are bracing for impact as broad U.S. import tariffs reshape commerce. 
Via Talk Markets
Topics ETFs Stocks / Equities World Trade
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies
Even as Donald Trump paused the reciprocal tariffs for 90 days, he later confirmed that pharmaceutical companies would face tariffs. 
Via Benzinga
Topics Government World Trade
6 Stocks With Clear Price Dislocations That I Purchased During Wall Street's Historic Volatility
Though the stock market is still historically pricey, a few phenomenal bargains have cropped up. 
Via The Motley Fool
Topics Government Stocks World Trade
Novavax Retail Traders Rally In Defense After RFK Jr.'s COVID-19 Vaccine Skepticism Sends Stock Tumbling
Kennedy singled out the Novavax COVID-19 shot's single-antigen composition as the reason behind the delay in granting full approval. 
Via Stocktwits
What's going on in today's session: S&P500 most active stocks
Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Thursday. Discover the stocks that are generating the highest... 
Via Chartmill
Select Medical, Phreesia, Eli Lilly, Pfizer, and Brink's Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after stocks gave back some of the gains from the previous day as the White House clarified the tariffs on imports from China would add up to 145%,... 
Via StockStory
Topics Economy Government World Trade
S&P, Dow Jones Pharma Names Rattled — Again — On Trump's Tariffs Whiplash
Here's why the 90-day tariffs delay doesn't help pharmaceutical companies. 
Via Investor's Business Daily
Topics Government Stocks World Trade
Trump Wants RFK Jr. To 'Go Wild' On Health Care. What This Means For Biotech Stocks.
From vaccines to fluoride and beef tallow, here's where Robert F. Kennedy Jr. is making changes to health care. 
Via Investor's Business Daily
Topics Government
3 Hated Stocks with Mounting Challenges
Rock-bottom prices don't always mean rock-bottom businesses. The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value... 
Via StockStory
Topics Supply Chain
Pfizer Invites Shareholders to Attend Virtual 2025 Annual Meeting of Shareholders on April 24
From Pfizer Inc.
Via Business Wire
Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline
Trump hints at major tariffs on foreign pharmaceuticals, sparking concerns for Indian suppliers and potential hikes in U.S. drug costs. 
Via Benzinga
Topics Government Supply Chain World Trade
Most active S&P500 stocks in Wednesday's session
Looking for the most active S&P500 stocks in today's session? Join us as we dive into the US markets on Wednesday and discover the stocks that are dominating the trading activity and setting the pace... 
Via Chartmill
< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.